Cargando…

Influence of insulin clearance to glucose tolerance in acutely ill severe patients: analysis with glucose clamp method by means of artificial pancreas

Detalles Bibliográficos
Autores principales:	Hoshino, M, Haraguchi, Y, Sakai, M, Mizushima, I, Morita, Y, Kobayashi, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301452/ http://dx.doi.org/10.1186/cc1896

Ejemplares similares

Investigation of the factors which influence insulin sensitivity in septic patients with glucose intolerance: analysis with glucose clamp method by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2002)

Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2001)

Investigation of insulin clearance in severely acutely ill patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2007)

Evaluation of glucose intolerance in acutely ill severe patients by means of an artificial pancreas
por: Hoshino, M, et al.
Publicado: (2004)

Influence of blood glucose-related factors to glucose tolerance in acutely ill severe patients evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2005)

Significance of the suppression of blood glucose variability in acutely ill severe patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2008)

Investigation of the blood glucose target for mortality reduction by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2011)

Relationship between blood glucose level and outcome in acutely ill severe patients with glucose intolerance evaluated by means of a bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2006)

Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (1998)

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas
por: Hoshino, M, et al.
Publicado: (1999)

Significance of blood glucose variability in the early phase for predicting survival in acutely ill patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2010)

High blood glucose variability in acute phase is one of the most important risk factors relating to the outcome in acutely ill severe patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2009)

Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2000)

Glycaemia influences glucose metabolism in sepsis during hyperinsulinemic clamp
por: Rušavý, Z, et al.
Publicado: (1998)

Blood glucose target in acute phase suggested by the analysis of the relationship between blood glucose profile and the severity of the diseases
por: Hoshino, M, et al.
Publicado: (2014)

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001)

Artificial Neural Networks Based Controller for Glucose Monitoring during Clamp Test
por: Catalogna, Merav, et al.
Publicado: (2012)

Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring
por: Ramkissoon, Charrise M., et al.
Publicado: (2018)

Association of pulse pressure with fasting and 2-h plasma glucose in subjects with different degrees of glucose tolerance
por: Silva, Letícia Maria Tedesco, et al.
Publicado: (2015)

Variable and maximum blood glucose levels during the first week after ICU admission are related to the severity of the patients
por: Hoshino, M, et al.
Publicado: (2012)

Plasma Lactate Levels Increase during Hyperinsulinemic Euglycemic Clamp and Oral Glucose Tolerance Test
por: Berhane, Feven, et al.
Publicado: (2015)

Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans
por: Nakanishi, Shuhei, et al.
Publicado: (2013)

Experience of medical examination and health consultation for public exposed to neutrons caused by criticality incident in Japan
por: Haraguchi, Y, et al.
Publicado: (2000)

Meaning of upper limit of normal range of post‐load 1‐h plasma glucose level defined by oral glucose tolerance test in Japanese subjects
por: Iwao, Tadashi, et al.
Publicado: (2013)

Acute necrotizing pancreatitis — histological study focusing on necrosis and apoptosis
por: Haraguchi, Y, et al.
Publicado: (2000)

Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
por: Blauw, H., et al.
Publicado: (2016)

Accuracy of insulin resistance indices for metabolic syndrome in a population with different degrees of glucose tolerance
por: Antoniolli, Luciana Pavan, et al.
Publicado: (2015)

Waist-to-height ratio as a predictor of metabolic syndrome in a population with different degrees of glucose tolerance
por: Pazinato, Tássia Cividanes, et al.
Publicado: (2015)

Nicotinamide Mononucleotide Prevents Free Fatty Acid-Induced Reduction in Glucose Tolerance by Decreasing Insulin Clearance
por: Nahle, Ashraf, et al.
Publicado: (2021)

Accuracy and stability of an arterial sensor for glucose monitoring in a porcine model using glucose clamp technique
por: Aberer, Felix, et al.
Publicado: (2020)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

A Novel Needle-Injectable Millimeter scale Wireless Electrochemical Glucose Sensing Platform for Artificial Pancreas Applications
por: Mujeeb-U-Rahman, M., et al.
Publicado: (2019)

Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis
por: Zeng, Baoqi, et al.
Publicado: (2022)

Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans
por: Ohashi, Kaoru, et al.
Publicado: (2015)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice
por: Ahrén, Bo, et al.
Publicado: (2020)

Prediction of Glucose Tolerance without an Oral Glucose Tolerance Test
por: Babbar, Rohit, et al.
Publicado: (2018)

Hyperinsulinaemic–hypoglycaemic glucose clamps in human research: a systematic review of the literature
por: Fabricius, Therese W., et al.
Publicado: (2021)

Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring: A safety net for the artificial pancreas
por: Dassau, Eyal, et al.
Publicado: (2010)

FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization
por: Kikuchi, Osamu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_prm36hpoltme2eiealv1v6na5q